Hibitane 5%

Quick links to important sections

Medically reviewed

Laura Arias

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Hibitane 5%

Quick Facts

Property Description
Active ingredient Chlorhexidine Gluconate (5% concentration)
Form Concentrated Solution (Aqueous liquid)
Pharmacological class Antiseptic and Disinfectant (Cationic bis-guanide)
Common purpose Infection prophylaxis and microbial load reduction
Origin Synthetic

What is Hibitane 5% and What is its Pharmacological Class?

Hibitane 5% is a synthetic medicinal preparation primarily classified as a powerful antiseptic and disinfectant used for hygiene and infection control. Its identity is defined by its sole active component, Chlorhexidine Gluconate, an effective antimicrobial agent that is clinically recognized for its broad-spectrum efficacy against many pathogens. This compound is a widely recognized substance, often included on essential medicine lists.

This solution belongs to the cationic bis-guanide chemical group, a distinct pharmacological class. This classification is significant as pharmacological studies confirm its sustained action, demonstrating its effectiveness in maintaining residual antimicrobial activity on the skin after use. The general purpose is foundational: to support hygiene standards and contribute to infection prophylaxis by chemically reducing the microbial load on both living tissue and inanimate surfaces.


Composition, Form, and General Purpose

The preparation is a single-ingredient product supplied as a highly Concentrated Solution, containing Chlorhexidine Gluconate at a 5% concentration in an aqueous vehicle. This liquid formulation is exclusively intended for topical use.

The concentrated solution form is a key feature, as it is marketed for versatility and cost-effectiveness. This liquid necessitates dilution, distinguishing it from lower-concentration, ready-to-use formulations. Its general purpose is directly tied to improving outcomes in procedures where controlling microbial presence is critical, such as when used for pre-operative skin preparation.

Regulatory References

  1. WHO Essential Medicines

What side effects are possible with Hibitane 5%?

Possible Side Effects and Safety Information

The official safety profile for Hibitane 5% (Chlorhexidine Gluconate) is primarily structured around the potential for localized skin reactions and systemic allergic responses, as documented in government regulatory labeling.

Documented Adverse Reactions

The most frequent adverse reactions are generally localized and involve the skin, classified under Skin and subcutaneous tissue disorders. These include allergic skin reactions such as dermatitis, pruritus, urticaria, erythema, and general skin irritation. The frequency for many of these localized effects is often classified as Not Known (cannot be estimated from available data).

Classification Serious Adverse Reaction
Immune system disorders Anaphylactic Shock

Anaphylactic shock is a Rare but severe, life-threatening allergic reaction that constitutes the highest tier of reported risk in regulatory safety summaries, occurring within minutes of exposure.


Safety Constraints and Special Populations

Specific regulatory constraints define the safe use of this concentrated solution. The product is contraindicated in individuals with a known history of hypersensitivity to Chlorhexidine Gluconate. Use is strictly limited to external application.

Critical safety restrictions dictate that the product must not be used in the eye, middle ear, or in the subarachnoid space, and contact with meninges must be avoided due to neurotoxicity concerns.

A specific warning exists for neonates and infants: regulatory documents note the reported risk of chemical burns when the solution is applied to the delicate skin of premature infants or over large surface areas. Furthermore, the antiseptic effect can be compromised when the preparation is used concurrently with anionic agents such as soaps.

Overdose and Emergency Response

Overdose and when to seek help

Overdose situations for Chlorhexidine Gluconate 5% are defined by two severe risks: systemic toxicity following accidental ingestion of the concentrated solution and the potential for life-threatening anaphylaxis. Systemic toxicity from ingestion can lead to neurological signs such as headache, euphoria, giddiness, blurred vision, uncoordinated movement, or unconsciousness. Additional presentations include gastrointestinal effects (stomachache, bloody vomiting, diarrhea) and cardiovascular findings like hypotension and tachycardia. Severe outcomes include shock and the risk of Acute Respiratory Distress Syndrome (ARDS) following aspiration.

When to Seek Urgent Help

Regulatory authorities mandate seeking immediate medical attention or calling emergency services if symptoms of a severe allergic reaction (e.g., swelling, wheezing, difficulty breathing) occur. Immediate medical help must also be sought if the product is swallowed. Management is based on symptomatic and supportive treatment, as no specific antidote is known. Hospitalization and continuous monitoring of vital signs may be required, and decontamination procedures like activated charcoal may be used. Due to increased local risk, special consideration for tissue injury is noted for infants under 2 months of age. If eye contact occurs, the eye must be rinsed promptly and thoroughly with water.

Therapeutic Uses of Hibitane 5%

What Hibitane 5% Treats: Main Uses and Benefits

The therapeutic utility of Hibitane 5% (Chlorhexidine Gluconate 5%) is defined by its effective role as a topical antiseptic relevant for infection control. This anti-infectant agent is applied to help reduce microbial presence on the skin, which assists in managing infectious risk.

This preparation is commonly used across a range of clinical settings for conditions that involve a high risk of microbial contamination. Key applications include prophylactic reduction of infectious risk before surgical and vascular access procedures; antiseptic cleansing of acute traumatic wounds, minor superficial burns, and chronic skin ulcers; and specialized infection control in maternal and neonatal care.

The general benefit is providing support that helps ease the overall symptom burden associated with potential infection. Its role is primarily associated with reducing microbial presence to help prevent symptoms related to infection. This action is relevant for easing the infectious risk associated with procedures and may assist in managing the risk of localized contamination escalating to a more serious state.


Quick Fact: Relief for Infectious Risk

Property Description
Primary Domain Infection Control and Prophylaxis
Symptom Cluster High localized microbial load, risk of wound contamination
Patient Benefit Supports patients during episodes of heightened discomfort; assists in managing infectious risk
Relevant Scenario Pre-operative skin preparation, wound cleansing, neonatal cord care

Regulatory References

  1. NIH MedlinePlus Drug Information on Chlorhexidine Topical

Eligibility and Restrictions for Use

Who Can and Cannot Use Hibitane 5%?

This section defines the eligibility for using Hibitane 5% (Chlorhexidine Gluconate 5% concentrate) based strictly on regulatory documentation, detailing who is prohibited from use and who must exercise caution.


Populations Prohibited from Use (Contraindications)

Use is absolutely contraindicated in patients with a known hypersensitivity or allergy to chlorhexidine or any component in the preparation. The solution must never be used in contact with nervous tissue (such as the brain or meninges) or in specific serous cavities, including the middle ear, due to the risk of serious local injury. The product is strictly for external application.


Populations Requiring Caution and Restriction

Population Group Regulatory Status and Condition
Infants/Neonates Use with extreme caution due to high risk of chemical burns from sensitive skin, especially in preterm infants.
Pregnancy/Lactation Generally permitted, but breastfeeding women must not apply the solution to the breast area to prevent ingestion by the infant.
Damaged Skin/Burns Conditional use required on large areas of damaged skin (e.g., severe burns) due to the potential for increased systemic absorption.

Eligibility for adults and older adults is generally permitted under standard labeled conditions. Renal or hepatic impairment does not typically impose specific eligibility restrictions for topical use, as systemic absorption is negligible.

What should I know about interactions with other medicines?

Interactions with other medicines and products

The official regulatory profile for Hibitane 5% focuses primarily on local chemical incompatibilities rather than systemic drug interactions. Due to the minimal systemic absorption of Chlorhexidine Gluconate from topical application, regulatory documentation confirms there are no documented pharmacokinetic interactions involving drug transporters or metabolic enzymes (CYP).


Restrictions Based on Chemical Incompatibility

The essential interaction restriction is governed by the product’s chemistry, where the cationic active ingredient is chemically incompatible with anionic agents, such as soap. Co-administration or contact with these substances results in precipitation and a consequent loss of the solution’s antimicrobial activity. The regulatory constraint requires that Hibitane 5% must not be co-administered with any anionic agents to preserve its antiseptic function.


Procedural and Product-Based Constraints

Regulatory documents note specific procedural restrictions and product interactions:

  • Peritoneal Dialysis: Diluted solutions must not be used for the disinfection of peritoneal dialysis catheters due to the risk of precipitation.
  • Cleaning Agents: A non-therapeutic chemical interaction is documented with hypochlorite bleaches, which may cause brown staining on fabrics that have been previously exposed to Chlorhexidine Gluconate.

Mechanism of Action

Direct Disruption of Microbial Cell Integrity

The action of Hibitane 5% begins with the cationic bis-guanide molecule's strong attraction to the negatively charged microbial cell membrane. This binding initiates a physical-chemical cascade that rapidly compromises the cell's structural integrity, leading to an uncontrolled efflux of vital molecules like ATP. This immediate disruption is the primary mechanism for the irreversible termination of microbial cellular function.


Concentration-Dependent Cidal Mechanism

The molecule's effect is executed through a concentration-dependent cidal cascade. At working concentrations, the initial membrane damage is followed by the molecule penetrating the cell and causing the coagulation of essential intracellular proteins and nucleic acids. This dual-action physical destruction limits the microbe's ability to maintain function or replicate, thereby achieving a reduction of the microbial load.


Mechanistic Substantivity and Residual Action

A unique mechanistic domain involves the electrostatic binding of the cationic ingredient to anionic keratin proteins on the skin's surface. This interaction creates a localized reservoir that results in the prolonged, slow release of the active ingredient. This mechanism of substantivity results in a sustained antimicrobial effect on the application site's surface long after the initial use.

Dosage and Administration Information

How to Use Hibitane 5% (Chlorhexidine Gluconate Concentrate)

Hibitane 5% is a concentrated solution of Chlorhexidine Gluconate and must be diluted before use. It is strictly for external/topical application only. It must never be used undiluted, ingested, or injected. The concentrated solution is not suitable for use in sensitive areas such as the eyes, middle ear, or internal body cavities.


Official Dilution and Administration

Proper use requires preparing specific concentrations for the intended application, as defined in regulatory guidelines. The diluted solution should be prepared immediately before use and must not be stored due to the risk of bacterial contamination.

Target Concentration Preparation Method (Dilution of 5% Concentrate) Labeled Use Context
0.05% Aqueous (1 in 2000) 10 ml of concentrate diluted to 1 litre with water. Swabbing wounds and burns; storage of sterile instruments.
0.5% in 70% Alcohol (1 in 200) 10 ml of concentrate mixed with 70% alcohol to 100 ml total volume. Preoperative skin disinfection; emergency instrument immersion.

Important Procedural Requirements

  1. Water Quality: Use clear water, often recommended to be boiled and cooled, for preparing aqueous dilutions, especially for application to broken skin.
  2. Incompatibilities: Avoid contact with soaps, detergents, and other anionic agents, as these may reduce the effectiveness of the product.
  3. Drying: If using an alcoholic solution for skin preparation (e.g., prior to surgery), the solution must be allowed to dry completely before using surgical tools like diathermy or cautery.
  4. Rinsing: Any instruments, such as syringes or needles, that have been immersed in the solution must be thoroughly rinsed with sterile water or saline before use to prevent irritation.

Recent Clinical Evidence

Research evidence / Overview of Studies for Hibitane 5%


Evidence for Use in Infection Prophylaxis

Research exploring the use of Chlorhexidine-containing solutions for cleaning skin before an operation has involved numerous Randomized Controlled Trials (RCTs) and comprehensive Systematic Reviews. These studies primarily examine the role of the antiseptic in studies that tracked the incidence of infection after surgery. Researchers measured outcomes related to the incidence of Surgical Site Infection (SSI), which includes both superficial and deep infections, along with changes in the amount of bacteria present on the patient's skin before and after the application. Study populations generally consist of adult patients preparing for various planned operations, including cardiac and general surgeries.

Findings describe patterns observed where one preparation was associated with differences in SSI rates compared to others in certain surgical patient groups. Research highlights changes measured during the study period, particularly a measured shift in the microbial load tracked on the skin. A key uncertainty is the need for more specific data regarding the 5% Chlorhexidine Gluconate solution itself (before dilution), as studies frequently involve comparisons with other antiseptic options.


Evidence in Critical Care and Hospital Infection Prevention

Studies exploring the use of antiseptic cleansing products containing Chlorhexidine in hospital settings, such as Intensive Care Units (ICUs), include Cluster RCTs and Observational Cohort Studies. Researchers monitored whether the application of these agents was associated with changes in the frequency of serious infections. Research examined outcomes related to Central-Line Associated Bloodstream Infections (CLABSI), general bloodstream infections, and the acquisition of antibiotic-resistant organisms.

Evidence is limited in that a substantial amount of the data for daily bathing protocols involves lower-concentration preparations, such as pre-moistened cloths containing 2% Chlorhexidine, rather than the 5% concentrated solution. Findings were mixed or inconsistent when comparing different types of ICUs, and certainty remains low because many of the studies were non-randomized.


Long-Term Studies and Follow-up Durations

Research has explored short-term differences measured during the study period, with most reported outcomes assessed within 30 to 90 days post-procedure for surgical infection research. Evidence is limited for long-term outcomes and the durability of the observed patterns following the discontinuation of Chlorhexidine use. Data are still emerging, and certainty remains low regarding effects that might be observed six months or a year after application.

Key Studies & References

  1. WHO Essential Medicines List (EML) for Selection and Use
  2. NIH MedlinePlus Drug Information on Chlorhexidine Topical

Frequently Asked Questions (FAQ)

Common questions about Hibitane 5% (FAQ)


Q: How quickly does Hibitane 5% start to work?

Official product information describes the active ingredient, Chlorhexidine Gluconate, as initiating a physical-chemical cascade that rapidly compromises the structure of microbial cells. This immediate disruption is the primary mechanism cited for the rapid termination of microbial cellular function.


Q: Can children use Hibitane 5%?

Official labeling generally indicates that the product is not recommended for use in infants younger than two months old. This restriction is due to potential safety concerns, including the risk of increased absorption of the active ingredient through delicate skin. Regulatory eligibility for older children is generally permitted under standard labeled conditions.


Q: Can I use Hibitane 5% with other topical creams?

According to official product warnings, the active ingredient is chemically incompatible with anionic agents, which include most soaps and detergents. Contact with these substances should be avoided as it can cause the solution to precipitate and lose its antimicrobial effectiveness. Information regarding incompatibility may require reviewing the components of other topical products for anionic agents.


Q: Is a rash a common side effect of Hibitane 5%?

The official safety profile lists localized skin reactions, such as irritation, dermatitis, and rash, among the reported adverse effects. However, the frequency of these particular reactions is often officially classified as 'Not Known' because it cannot be accurately estimated from the available data.


Q: What is the difference between Hibitane 5% and regular antiseptic wipes?

Hibitane 5% is a highly concentrated solution of Chlorhexidine Gluconate, which means it must be diluted to the correct strength before application. In contrast, many antiseptic wipes and washes are already prepared at a lower, ready-to-use concentration (often 2% or less). The concentrated form is typically used in clinical settings to prepare different working strengths for various applications.


Q: Can Hibitane 5% be used on broken skin or deep wounds?

Official warnings indicate that when the solution is applied to large areas of damaged skin, such as severe burns, it must be used with caution. This is due to the potential for increased absorption of the active ingredient into the body. Diluted solutions are used in the swabbing of wounds and burns, though caution remains essential for large, deep areas.


Q: Do studies support the long-term use of Hibitane 5% for skin cleansing?

Research evidence, as summarized in regulatory documents, indicates that studies primarily focus on short-term outcomes, generally within 30 to 90 days post-procedure. Evidence is therefore limited regarding the effects and durability of antimicrobial patterns for long-term use, especially following discontinuation of the product.


Q: Can people with sensitive skin use Hibitane 5%?

Regulatory warnings indicate that the product is strictly contraindicated for anyone with a known hypersensitivity or allergy to the active ingredient. Additionally, the list of adverse effects includes localized reactions such as skin irritation and dermatitis, which are conditions often experienced by individuals with sensitive skin. Due to the documented potential for these adverse skin reactions, caution is advised for individuals with known skin sensitivities.


Q: Can Hibitane 5% be used on different parts of the body?

The product is intended strictly for external and topical application to the skin. Official documents clearly prohibit its use in sensitive areas due to risk of injury, including the eye, the middle ear, and in contact with nervous tissue.


Q: Is the 5% concentration significant compared to other products?

The 5% concentration distinguishes the product as a concentrate rather than a ready-to-use solution. This form requires mandatory dilution to achieve the correct lower working concentration (such as 0.05% or 0.5% in alcohol) for various applications.


Q: Is Hibitane 5% flammable?

While the aqueous concentrate itself is generally not flammable, the solution can become highly flammable when diluted with alcohol for certain skin preparation uses. Regulatory documents require that any alcoholic dilution must be allowed to dry completely before using heat-generating tools like cautery during procedures.


Q: How is the term 'antiseptic' defined in relation to Hibitane 5%?

Hibitane 5% is classified as an antiseptic and disinfectant. An antiseptic is defined in this context as an agent used on living tissue to chemically reduce the microbial load (the number of microorganisms). Its purpose is to support hygiene standards and aid in infection prophylaxis (prevention).


Q: How does the concentration of Hibitane 5% relate to its speed of action?

The efficacy of the active ingredient is described as operating through a concentration-dependent cidal cascade. This describes how the specific working concentration influences the scale of the antimicrobial action. Higher working concentrations cause more profound damage, coagulating essential proteins inside the microbial cell.


Q: Can I use Hibitane 5% if I have a chronic skin condition like eczema?

Official product warnings list adverse reactions such as skin irritation, pruritus, and dermatitis (a form of skin inflammation) that can occur upon use. Due to the documented potential for adverse skin reactions like dermatitis and irritation, caution is advised when using this product on inflamed or compromised skin.


Q: Does Hibitane 5% sting or burn when applied?

The official safety profile includes localized adverse reactions such as skin irritation and erythema (skin redness). While a specific sensation of stinging or burning is not explicitly listed, these documented reactions may be accompanied by such feelings.


Q: Does Hibitane 5% cause skin dryness?

Regulatory documentation for the topical solution does not explicitly list skin dryness as a common adverse reaction. However, the safety profile does include the potential for localized skin irritation and dermatitis, which are more severe forms of skin reaction.


Q: Does using Hibitane 5% regularly lead to resistance?

Studies examining the regular use of chlorhexidine formulations in clinical settings, such as oral rinse preparations, did not find significant evidence of changes in bacterial resistance or overgrowth of opportunistic organisms during a six-month observation period.


Q: Is Hibitane 5% a prescription-only medicine?

The active ingredient, Chlorhexidine Gluconate, is available in many different formulations (washes, solutions, swabs). Its regulatory status can vary, as it is available both as an over-the-counter (OTC) product and as a prescription-only medicine, depending on the specific concentration and the intended medical use.


Q: Are there different versions or brands of Hibitane 5%?

The product name 'Hibitane 5%' refers to a specific concentrated solution containing the active ingredient, Chlorhexidine Gluconate. This active ingredient is widely used and is the basis for numerous products available under various brand names and generic forms worldwide.


Q: What information is publicly available about the non-active ingredients in Hibitane 5%?

Official documents confirm that the concentrate is prepared using an aqueous vehicle (water-based solution). The specific non-active ingredients, or excipients, used in all commercially available chlorhexidine formulations are publicly listed on their respective regulatory labels.


Q: Does the color of the solution indicate anything about its effectiveness?

Chlorhexidine concentrates are often described in official documents as being a clear liquid. While regulatory documentation warns that contact with hypochlorite bleaches can cause fabric staining, there is no official statement indicating that the color of the solution itself is used as an indicator of its effectiveness.


Q: What is the half-life of the active ingredient in Hibitane 5%?

Official regulatory reviews of the active ingredient, Chlorhexidine Gluconate, note that it is poorly absorbed when applied topically to the skin. Because the amount that reaches the bloodstream is minimal, the systemic half-life is not considered a primary factor for this topical application, unlike for products that are fully ingested.


Q: Does Hibitane 5% have any effect on viruses?

Regulatory review documents describe Chlorhexidine Gluconate as being effective against a wide range of microorganisms, including bacteria, yeasts, and fungi. It is also described as being effective against certain types of viruses known as lipophilic viruses, which are those possessing a lipid (fatty) envelope.


Q: Is there a maximum amount of time someone is described as using Hibitane 5% for?

Official product information includes a precaution against using the solution for an extended period of time on large areas of the body. Instructions about the total duration of use for the product in any specific application are typically found within the regulatory guidance for the intended procedure.


Q: Why is the safety classification of Hibitane 5% considered important?

The safety classification is important because it is established based on potential risks identified in official regulatory reviews. This classification dictates mandatory restrictions, such as absolute contraindications (prohibitions of use) for people with known hypersensitivity, and specific warnings for sensitive populations like infants, all of which are designed to prevent serious injury.

How should Hibitane 5% be stored and disposed of?

How to Store and Dispose of Hibitane 5% Concentrate

Storage Conditions

Hibitane 5% concentrate must be stored below 25 C and protected from light in a cool, dry, and well-ventilated area. It is mandatory to keep the container tightly closed and store the product in its original container, away from heat. The label requires that the concentrate must not be frozen and must be kept out of the reach of children.

Stability and Handling

The stability rules state that once the concentrate is diluted for use, the resulting solution must be used immediately and not stored.

Disposal Requirements

Disposal of unused or expired product must be done in accordance with local, regional, and national regulations. It is strictly required to avoid release to the environment; the product must not be allowed to enter the sewage system or waterways due to its ecotoxic classification.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Hibitane 5% found in:

A-Z Index: